Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography
Journal article published in 2001 by
P. Piccini,
J. de Yebenez,
A. J. Lees,
R. Ceravolo 
,
N. Turjanski,
P. Pramstaller,
D. J. Brooks
,
N. Turjanski,
P. Pramstaller,
D. J. Brooks
Abstract
Progressive supranuclear palsy (PSP) is generally considered to be a sporadic disease; however, occasional cases of familial PSP have been described. The rarity of reports of familial PSP may be attributed in part to an inability to detect subclinical disease in affected relatives who subsequently die before symptoms clinically develop.